ATE474842T1 - Neues verfahren zur herstellung von 5-amino-3h- thiazoloä4,5-düpyrimidin-2-on - Google Patents
Neues verfahren zur herstellung von 5-amino-3h- thiazoloä4,5-düpyrimidin-2-onInfo
- Publication number
- ATE474842T1 ATE474842T1 AT06846356T AT06846356T ATE474842T1 AT E474842 T1 ATE474842 T1 AT E474842T1 AT 06846356 T AT06846356 T AT 06846356T AT 06846356 T AT06846356 T AT 06846356T AT E474842 T1 ATE474842 T1 AT E474842T1
- Authority
- AT
- Austria
- Prior art keywords
- thiazoloa4
- düpyrimidin
- amino
- producing
- new process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73805505P | 2005-11-21 | 2005-11-21 | |
| PCT/US2006/061111 WO2007062355A2 (en) | 2005-11-21 | 2006-11-20 | PROCESS FOR THE PREPARATION OF 5-AMINO-3H- THIAZOLO [4 , 5 -d] PYRIMIDIN- 2 -ONE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE474842T1 true ATE474842T1 (de) | 2010-08-15 |
Family
ID=37908057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06846356T ATE474842T1 (de) | 2005-11-21 | 2006-11-20 | Neues verfahren zur herstellung von 5-amino-3h- thiazoloä4,5-düpyrimidin-2-on |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7781581B2 (de) |
| EP (1) | EP1973920B1 (de) |
| JP (1) | JP5117391B2 (de) |
| KR (1) | KR20080090400A (de) |
| CN (1) | CN101365705A (de) |
| AR (1) | AR058210A1 (de) |
| AT (1) | ATE474842T1 (de) |
| AU (1) | AU2006318260B2 (de) |
| BR (1) | BRPI0618789A2 (de) |
| CA (1) | CA2630463C (de) |
| DE (1) | DE602006015700D1 (de) |
| EA (1) | EA200801404A1 (de) |
| ES (1) | ES2345904T3 (de) |
| IL (1) | IL191568A0 (de) |
| NO (1) | NO20082365L (de) |
| SG (1) | SG152296A1 (de) |
| TW (1) | TWI383987B (de) |
| WO (1) | WO2007062355A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2655904C (en) | 2006-06-22 | 2014-11-18 | Anadys Pharmaceuticals, Inc. | Prodrugs of 5-amino-3-(3'-deoxy-.beta.-d-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione |
| JPWO2012102366A1 (ja) * | 2011-01-28 | 2014-06-30 | 日本たばこ産業株式会社 | 新規ピペラジン化合物の製造方法 |
| CN103012284A (zh) * | 2012-12-26 | 2013-04-03 | 无锡捷化医药科技有限公司 | 一种2-氨基-5-溴嘧啶类化合物的制备方法 |
| HUE053704T2 (hu) | 2014-12-08 | 2021-07-28 | Hoffmann La Roche | 3-szubsztitutált 5-amino-6H-tiazolo[4,5-d]pirimidin-2,7-dion vegyületek vírusfertõzések kezelésére és megelõzésére |
| WO2018127525A1 (en) | 2017-01-06 | 2018-07-12 | F. Hoffmann-La Roche Ag | PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-d]PYRIMIDINE-2,7-DIONE COMPOUNDS |
| CN111635368B (zh) * | 2020-06-12 | 2021-06-29 | 东莞市东阳光仿制药研发有限公司 | 一种胺化合物的制备方法 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4539205A (en) | 1982-11-09 | 1985-09-03 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
| US4643992A (en) | 1982-11-09 | 1987-02-17 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
| US5166141A (en) | 1983-11-01 | 1992-11-24 | Scripps Clinic And Research Foundation | Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals |
| US4746651A (en) | 1983-11-01 | 1988-05-24 | Scripps Clinic And Research Foundation | Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives |
| US5011828A (en) | 1985-11-15 | 1991-04-30 | Michael Goodman | Immunostimulating guanine derivatives, compositions and methods |
| GB8712745D0 (en) | 1987-05-30 | 1987-07-01 | Wellcome Found | Antiviral compounds |
| US5041426A (en) | 1987-12-21 | 1991-08-20 | Brigham Young University | Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides |
| US4880784A (en) | 1987-12-21 | 1989-11-14 | Brigham Young University | Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives |
| US5041542A (en) | 1988-06-03 | 1991-08-20 | Nucleic Acid Research Institute | Substituted pyrimido[5,4-d]pyrimidine nucleosides |
| GB9015914D0 (en) | 1990-07-19 | 1990-09-05 | Wellcome Found | Heterocyclic compounds |
| US5248672A (en) | 1990-11-01 | 1993-09-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazole nucleosides as antiviral agents |
| GB9105899D0 (en) | 1991-03-20 | 1991-05-08 | Wellcome Found | Therapeutic nucleosides |
| AU5165793A (en) | 1992-10-01 | 1994-04-26 | Mcneilab, Inc. | Derivatives of 7,8-disubstituted guanosines |
| GB9301000D0 (en) | 1993-01-20 | 1993-03-10 | Glaxo Group Ltd | Chemical compounds |
| US5395937A (en) | 1993-01-29 | 1995-03-07 | Minnesota Mining And Manufacturing Company | Process for preparing quinoline amines |
| US5446045A (en) | 1993-12-20 | 1995-08-29 | Revankar; Ganapathi R. | Antiviral guanine analogs |
| US5994321A (en) | 1993-12-20 | 1999-11-30 | Aronex Pharmaceuticals, Inc. | Antiviral guanine analogs |
| US5496816A (en) | 1994-03-14 | 1996-03-05 | Merck & Co., Inc. | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| JP4667543B2 (ja) | 1996-07-03 | 2011-04-13 | 大日本住友製薬株式会社 | 新規プリン誘導体 |
| US6509320B1 (en) | 1996-10-16 | 2003-01-21 | Icn Pharmaceuticals, Inc. | Purine L-nucleosides, analogs and uses thereof |
| AU727177B2 (en) | 1996-10-16 | 2000-12-07 | Icn Pharmaceuticals, Inc. | Purine L-nucleosides, analogs and uses thereof |
| JP4391592B2 (ja) | 1996-10-25 | 2009-12-24 | スリーエム カンパニー | Ｔｈ２介在性および関連疾患治療のための免疫応答修飾化合物 |
| JP4375901B2 (ja) | 1997-11-28 | 2009-12-02 | 大日本住友製薬株式会社 | 新規な複素環化合物 |
| TW572758B (en) | 1997-12-22 | 2004-01-21 | Sumitomo Pharma | Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives |
| WO1999051608A1 (en) * | 1998-04-03 | 1999-10-14 | Du Pont Pharmaceuticals Company | THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS |
| US6444652B1 (en) | 1998-08-10 | 2002-09-03 | Novirio Pharmaceuticals Limited | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
| US6667312B2 (en) | 2000-12-08 | 2003-12-23 | 3M Innovative Properties Company | Thioether substituted imidazoquinolines |
| US6664264B2 (en) | 2000-12-08 | 2003-12-16 | 3M Innovative Properties Company | Thioether substituted imidazoquinolines |
| US6545017B1 (en) | 2000-12-08 | 2003-04-08 | 3M Innovative Properties Company | Urea substituted imidazopyridines |
| US6664260B2 (en) | 2000-12-08 | 2003-12-16 | 3M Innovative Properties Company | Heterocyclic ether substituted imidazoquinolines |
| US6545016B1 (en) | 2000-12-08 | 2003-04-08 | 3M Innovative Properties Company | Amide substituted imidazopyridines |
| US20020086871A1 (en) | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
| JP4331944B2 (ja) | 2001-04-17 | 2009-09-16 | 大日本住友製薬株式会社 | 新規アデニン誘導体 |
| US7321033B2 (en) * | 2001-11-27 | 2008-01-22 | Anadys Pharmaceuticals, Inc. | 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof |
| WO2003045968A1 (en) | 2001-11-27 | 2003-06-05 | Anadys Pharmaceuticals, Inc. | 3-β-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF |
| BR0309581A (pt) | 2002-05-06 | 2005-03-29 | Genelabs Tech Inc | Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c |
| US7196090B2 (en) * | 2002-07-25 | 2007-03-27 | Warner-Lambert Company | Kinase inhibitors |
| WO2005016235A2 (en) | 2003-04-14 | 2005-02-24 | The Regents Of The University Of California | Combined use of impdh inhibitors with toll-like receptor agonists |
| AU2004247559B2 (en) * | 2003-06-12 | 2009-08-27 | Astellas Pharma Inc. | Benzamide derivative or salt thereof |
| EP1667694B1 (de) | 2003-09-05 | 2010-04-28 | Anadys Pharmaceuticals, Inc. | Tlr7-liganden zur behandlung von hepatitis c |
| CA2555914A1 (en) * | 2004-03-08 | 2005-09-22 | Amgen Inc. | Therapeutic modulation of ppar (gamma) activity |
| AU2005295453A1 (en) | 2004-10-15 | 2006-04-27 | Bayer Healthcare Llc | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |
| ES2459368T3 (es) | 2004-12-17 | 2014-05-09 | Anadys Pharmaceuticals, Inc. | Compuestos de 3H-oxazolo y 3H-tiazolo[4,5-d]pirimidin-2-ona 3,5-disustituidos y 3,5,7-trisustituidos y profármacos de los mismos |
| EP2392328A1 (de) | 2005-05-09 | 2011-12-07 | Hydra Biosciences, Inc. | Verbindungen zur Modulierung der TRPV3-Funktion |
| CA2655904C (en) | 2006-06-22 | 2014-11-18 | Anadys Pharmaceuticals, Inc. | Prodrugs of 5-amino-3-(3'-deoxy-.beta.-d-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione |
| EP2040712B1 (de) | 2006-07-18 | 2011-03-02 | Anadys Pharmaceuticals, Inc. | Carbonat- und carbamat-prodrugs von thiazolo [4,5-d]-pyrimidinen |
-
2006
- 2006-11-20 CA CA2630463A patent/CA2630463C/en not_active Expired - Fee Related
- 2006-11-20 SG SG200903039-6A patent/SG152296A1/en unknown
- 2006-11-20 AU AU2006318260A patent/AU2006318260B2/en not_active Ceased
- 2006-11-20 DE DE602006015700T patent/DE602006015700D1/de active Active
- 2006-11-20 ES ES06846356T patent/ES2345904T3/es active Active
- 2006-11-20 TW TW095142739A patent/TWI383987B/zh not_active IP Right Cessation
- 2006-11-20 CN CNA200680050892XA patent/CN101365705A/zh active Pending
- 2006-11-20 US US11/601,719 patent/US7781581B2/en not_active Expired - Fee Related
- 2006-11-20 EA EA200801404A patent/EA200801404A1/xx unknown
- 2006-11-20 JP JP2008541505A patent/JP5117391B2/ja not_active Expired - Fee Related
- 2006-11-20 EP EP06846356A patent/EP1973920B1/de not_active Not-in-force
- 2006-11-20 WO PCT/US2006/061111 patent/WO2007062355A2/en not_active Ceased
- 2006-11-20 AT AT06846356T patent/ATE474842T1/de not_active IP Right Cessation
- 2006-11-20 BR BRPI0618789A patent/BRPI0618789A2/pt not_active IP Right Cessation
- 2006-11-20 KR KR1020087014973A patent/KR20080090400A/ko not_active Withdrawn
- 2006-11-21 AR ARP060105089A patent/AR058210A1/es not_active Application Discontinuation
-
2008
- 2008-05-20 IL IL191568A patent/IL191568A0/en unknown
- 2008-05-26 NO NO20082365A patent/NO20082365L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2630463C (en) | 2015-01-06 |
| BRPI0618789A2 (pt) | 2016-08-30 |
| WO2007062355A2 (en) | 2007-05-31 |
| SG152296A1 (en) | 2009-05-29 |
| EP1973920A2 (de) | 2008-10-01 |
| KR20080090400A (ko) | 2008-10-08 |
| US7781581B2 (en) | 2010-08-24 |
| DE602006015700D1 (de) | 2010-09-02 |
| US20070117979A1 (en) | 2007-05-24 |
| JP2009516709A (ja) | 2009-04-23 |
| IL191568A0 (en) | 2008-12-29 |
| AU2006318260A1 (en) | 2007-05-31 |
| WO2007062355A3 (en) | 2007-07-26 |
| AR058210A1 (es) | 2008-01-23 |
| EP1973920B1 (de) | 2010-07-21 |
| EA200801404A1 (ru) | 2008-10-30 |
| CN101365705A (zh) | 2009-02-11 |
| AU2006318260B2 (en) | 2012-05-17 |
| JP5117391B2 (ja) | 2013-01-16 |
| TW200736265A (en) | 2007-10-01 |
| TWI383987B (zh) | 2013-02-01 |
| NO20082365L (no) | 2008-08-18 |
| CA2630463A1 (en) | 2007-05-31 |
| ES2345904T3 (es) | 2010-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE408604T1 (de) | Verfahren zur herstellung von 1-alkyl-3- phenyluracilen | |
| ATE522488T1 (de) | Verfahren zur herstellung von 1,2-dichlorethan | |
| ATE455105T1 (de) | Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten | |
| ATE408609T1 (de) | Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden | |
| ATE516816T1 (de) | Verfahren zur herstellung von impfstoffen | |
| EP2170785A4 (de) | Verfahren zur herstellung von hydrofluorolefinen | |
| ATE447555T1 (de) | Neues verfahren zur herstellung vonroflumilast | |
| ATE524426T1 (de) | Verfahren zur herstellung von 1,2-dichlorethan | |
| DE602005019848D1 (de) | Verfahren zur herstellung von tad- getrocknetem ti | |
| DE602007009096D1 (de) | Verfahren zur herstellung von benzopyran-2-olderivaten | |
| DE602006015090D1 (de) | Verfahren zur herstellung von gezielt durchlässigen laminaten | |
| DE502005010038D1 (de) | Verfahren zur herstellung von 3-pentennitril | |
| ATE518847T1 (de) | Verfahren zur herstellung von betamimetika | |
| DE602006018429D1 (de) | Verfahren zur herstellung von verschlüssen | |
| ATE529395T1 (de) | Verfahren zur herstellung von organischen carbonaten | |
| DE502006001281D1 (de) | Verfahren zur herstellung substituierter biphenyle | |
| ATE554088T1 (de) | Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten | |
| ATE507230T1 (de) | Neues stereospezifisches verfahren zur herstellung von dioxabicyclooctan-verbindungen | |
| ATE518829T1 (de) | Verfahren zur herstellung von escitalopram | |
| ATE444303T1 (de) | Verfahren zur herstellung von ferrisuccinylcasein | |
| DE502005001997D1 (de) | Verfahren zur herstellung von silanisierten kohlenstoff-nanoröhren | |
| DE602005021110D1 (de) | Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten | |
| ATE549314T1 (de) | Verfahren zur herstellung von 4-aminochinazolinen | |
| ATE392404T1 (de) | Verfahren zur herstellung von methanol | |
| ATE417839T1 (de) | Verfahren zur herstellung von amorolfin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |